My story: my Hepatitis C journey as a black american

Written by Michael Gollust. Medically reviewed in February 2024 by Mark Arredondo, MD.

Updated on October 23, 2024

Pat, a hepatitis c survivor, leads by example as a health advocate. In this video, Pat shares her thoughts on disparity within the healthcare system.

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.

Learn who has higher odds of contracting this viral infection.

From representation reflected in specialties of medical professionals, to balance within clinical trials, health equity is an ongoing evolution.

What You Need to Know About Hepatitis C and Its Genotypes